Research on New Prevention and Treatment Technology of Atrial Fibrillation and Stroke (efficacy and safety of catheter ablation for atrial fibrillation guided by noninvasive three-dimensional electrocardiographic mapping: a randomized controlled trial)
Not Applicable
Recruiting
- Conditions
- Atrial Fibrillation
- Registration Number
- ITMCTR1900002562
- Lead Sponsor
- First Affiliated Hospital of Zhejiang Chinese Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients diagnosed with paroxysmal and persistent atrial fibrillation;
2. Patients aged between 18 and 80 years old;
3. Patients undergoing atrial fibrillation radiofrequency catheter ablation;
4. Informed consent can be obtained.
Exclusion Criteria
1. Long-standing persistent or permanent atrial fibrillation;
2. Combined with other malignant arrhythmia such as sustained ventricular tachycardia;
3. Blood clots in the heart;
4. NYHA cardiac functional grading >=level III;
5. Other severe cardiac dysfunction, cardiac ion channel diseases, inherited arrhythmogenic diseases and so on;
6. Complicated with other severe diseases (e.g. hepatic and renal dysfunction, malignant tumor);
7. Pregnancy or be allergic to iodine contrast medium.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method successful rate;total procedure time;complication;whole fluoroscopic exposure;
- Secondary Outcome Measures
Name Time Method